E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/3/2010 in the Prospect News PIPE Daily.

New Issue: YM BioSciences settles $3.18 million private placement of common shares

By Devika Patel

Knoxville, Tenn., June 3 - YM BioSciences Inc. said it settled a $3.18 million non-brokered private placement of stock.

The company sold 2.5 million common shares at $1.27 per share.

Based in Mississauga, Ont., YM develops treatments for cancer.

Issuer:YM BioSciences Inc.
Issue:Common stock
Amount:$3,175,000
Shares:2.5 million
Price:$1.27
Warrants:No
Agent:Non-brokered
Settlement date:June 3
Stock symbol:NYSE Amex: YMI
Stock price:$1.32 at close June 2
Market capitalization:$100 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.